ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $608 | -79.1% | 405 | -77.8% | 0.00% | – |
| Q2 2023 | $2,905 | -99.7% | 1,827 | -99.8% | 0.00% | – |
| Q1 2023 | $868,000 | +123723.1% | 1,210,212 | 0.0% | 0.00% | – |
| Q4 2022 | $701 | -99.9% | 1,210,212 | -0.3% | 0.00% | – |
| Q3 2022 | $1,154,000 | -41.0% | 1,214,236 | -25.6% | 0.00% | – |
| Q2 2022 | $1,957,000 | -11.4% | 1,631,334 | -3.3% | 0.00% | – |
| Q1 2022 | $2,210,000 | -39.1% | 1,687,273 | -18.1% | 0.00% | – |
| Q4 2021 | $3,627,000 | -26.3% | 2,060,957 | -9.1% | 0.00% | -100.0% |
| Q3 2021 | $4,918,000 | -40.0% | 2,266,571 | -3.2% | 0.00% | 0.0% |
| Q2 2021 | $8,192,000 | -57.9% | 2,340,336 | +18.5% | 0.00% | -66.7% |
| Q1 2021 | $19,478,000 | +216.4% | 1,975,463 | +247.8% | 0.00% | +200.0% |
| Q4 2020 | $6,157,000 | +55.6% | 568,010 | +50.0% | 0.00% | 0.0% |
| Q3 2020 | $3,956,000 | -35.5% | 378,598 | +28.9% | 0.00% | 0.0% |
| Q2 2020 | $6,136,000 | +194.0% | 293,826 | +37.6% | 0.00% | – |
| Q1 2020 | $2,087,000 | -75.3% | 213,563 | -70.9% | 0.00% | -100.0% |
| Q4 2019 | $8,446,000 | +55.7% | 733,142 | -26.3% | 0.00% | +100.0% |
| Q3 2019 | $5,424,000 | -81.3% | 995,185 | -62.3% | 0.00% | -83.3% |
| Q2 2019 | $29,068,000 | +68.2% | 2,642,537 | -19.9% | 0.01% | +50.0% |
| Q1 2019 | $17,281,000 | +87.5% | 3,297,793 | +12.7% | 0.00% | +100.0% |
| Q4 2018 | $9,218,000 | -44.9% | 2,926,332 | +5.8% | 0.00% | -33.3% |
| Q3 2018 | $16,740,000 | +23.8% | 2,767,090 | +8.4% | 0.00% | 0.0% |
| Q2 2018 | $13,527,000 | +16.8% | 2,552,320 | +27.8% | 0.00% | +50.0% |
| Q1 2018 | $11,585,000 | +2396.8% | 1,997,407 | +1406.2% | 0.00% | – |
| Q4 2017 | $464,000 | +30.7% | 132,609 | +28.7% | 0.00% | – |
| Q3 2017 | $355,000 | +95.1% | 103,009 | +41.6% | 0.00% | – |
| Q2 2017 | $182,000 | -29.5% | 72,755 | -23.7% | 0.00% | – |
| Q1 2017 | $258,000 | -18.6% | 95,319 | -13.0% | 0.00% | – |
| Q4 2016 | $317,000 | +61.7% | 109,563 | +129.6% | 0.00% | – |
| Q3 2016 | $196,000 | +92.2% | 47,709 | +47.9% | 0.00% | – |
| Q2 2016 | $102,000 | – | 32,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |